Recombinant Humanized monoclonal antibody expressed in CHO binding to Human CD24. Anti-CD24 antibodiess and adjuvant combinations thereof with chemotherapeutic agents or toxins, which can be used to inhibit growth of CD24-expressing cancer cells and prevent and treat cancer.
Figure 1 Anti-Human CD24 Antibody (TAB-113CL) in ELISA
ELISA analysis of TAB-113CL was performed by coating with recombinant human CD24 (RPB143Hu01). Then blocked with BSA and incubated with Anti-Human CD24 Antibody (TAB-113CL) at a starting concentration of 1 ng/mL. The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
Figure 2 Anti-Human CD24 Antibody (TAB-113CL) in WB
Western blot analysis was performed by loading recombinant human CD24 (RPB143Hu01) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least 1 hour. Membranes were probed with Anti-Human CD24 Antibody (TAB-113CL) at a dilution of 1:1000 overnight at 4°C on a rocking platform. Then probed with Goat anti-Human IgG HRP secondary antibody at a dilution of 1:8,000 for one hour. Chemiluminescent was detected.
Lane 1: Non-Reducing Antigen (0.05 μg)
Lane 2: Reducing Antigen (0.05 μg)
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-006LC | Mouse Anti-CD24 Recombinant Antibody (TAB-006LC) | FC, FuncS | Mouse IgG2a |
TAB-006LC-S(P) | Mouse Anti-CD24 Recombinant Antibody; scFv Fragment (TAB-006LC-S(P)) | FC | Mouse scFv |
TAB-006LC-F(E) | Mouse Anti-CD24 Recombinant Antibody; Fab Fragment (TAB-006LC-F(E)) | FC | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-007LC | Human Anti-CD24 Recombinant Antibody (TAB-007LC) | FC | Humanized antibody |
TAB-007LC-S(P) | Human Anti-CD24 Recombinant Antibody; scFv Fragment (TAB-007LC-S(P)) | FC | Humanized scFv |
TAB-007LC-F(E) | Human Anti-CD24 Recombinant Antibody; Fab Fragment (TAB-007LC-F(E)) | FC | Humanized Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0434-CN | Mouse Anti-CD24 Recombinant Antibody (clone E4) | WB, ELISA, Neut | Mouse IgG1, κ |
FAMAB-1336CQ | Mouse Anti-CD24 Recombinant Antibody (clone YBM 5.10.4) | FC | Mouse IgG2a |
VS3-XY243 | Mouse Anti-CD24 Recombinant Antibody (clone 4F4E10) | ELISA, WB, FC | Mouse IgG1 |
VS-0723-WK207 | Human Anti-CD24 Recombinant Antibody (VS-0723-WK207) | ELISA, FC | Chimeric (rabbit/human) IgG1 |
VS-0723-WK217 | Human Anti-CD24 Recombinant Antibody (VS-0723-WK217) | ELISA, FC | Chimeric (rabbit/human) IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0434-CN-S(P) | Mouse Anti-CD24 Recombinant Antibody (clone E4); scFv Fragment | WB, ELISA, Neut | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0433-CN-F(E) | Mouse Anti-CD24 Recombinant Antibody (clone A7); Fab Fragment | WB, ELISA, Neut | Mouse Fab |
HPAB-0434-CN-F(E) | Mouse Anti-CD24 Recombinant Antibody (clone E4); Fab Fragment | WB, ELISA, Neut | Mouse Fab |
There are currently no Customer reviews or questions for TAB-113CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.